107 related articles for article (PubMed ID: 11605516)
1. [Trends in the pharmaceutical research of ribonucleases and their therapeutic uses].
Zhang Y; Li W; Su Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Sep; 18(3):456-60. PubMed ID: 11605516
[TBL] [Abstract][Full Text] [Related]
2. [Ribonucleases as antiviral agents].
Il'inskaia ON; Shakh Makhmud R
Mol Biol (Mosk); 2014; 48(5):707-17. PubMed ID: 25842855
[TBL] [Abstract][Full Text] [Related]
3. Ribonucleases and their antitumor activity.
Matousek J
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Jul; 129(3):175-91. PubMed ID: 11461835
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic ribonucleases and chimeras in cancer therapy.
Youle RJ; Newton D; Wu YN; Gadina M; Rybak SM
Crit Rev Ther Drug Carrier Syst; 1993; 10(1):1-28. PubMed ID: 8472310
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins.
Ruiz-de-la-Herrán J; Tomé-Amat J; Lázaro-Gorines R; Gavilanes JG; Lacadena J
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614771
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression.
Bedoya VI; Boasso A; Hardy AW; Rybak S; Shearer GM; Rugeles MT
AIDS Res Hum Retroviruses; 2006 Sep; 22(9):897-907. PubMed ID: 16989616
[TBL] [Abstract][Full Text] [Related]
7. On the track of antitumour ribonucleases.
Benito A; Ribó M; Vilanova M
Mol Biosyst; 2005 Oct; 1(4):294-302. PubMed ID: 16880994
[TBL] [Abstract][Full Text] [Related]
8. Microbial ribonucleases (RNases): production and application potential.
Hameş EE; Demir T
World J Microbiol Biotechnol; 2015 Dec; 31(12):1853-62. PubMed ID: 26433394
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemotherapy--ribonucleases to the rescue.
Leland PA; Raines RT
Chem Biol; 2001 May; 8(5):405-13. PubMed ID: 11358688
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleases and immunoRNases as anticancer drugs.
Rybak SM; Arndt MA; Schirrmann T; Dübel S; Krauss J
Curr Pharm Des; 2009; 15(23):2665-75. PubMed ID: 19689337
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapeutic RNases (ImmunoRNases).
Schirrmann T; Krauss J; Arndt MA; Rybak SM; Dübel S
Expert Opin Biol Ther; 2009 Jan; 9(1):79-95. PubMed ID: 19063695
[TBL] [Abstract][Full Text] [Related]
12. Refined immunoRNases for the efficient targeting and selective killing of tumour cells: A novel strategy.
Nassiri M; Behnam-Rasouli R; Vakili-Azghandi M; Gopalan V; Dolati P; Nourmohammadi R
Life Sci; 2022 Jan; 289():120222. PubMed ID: 34902436
[TBL] [Abstract][Full Text] [Related]
13. Modifications of Ribonucleases in Order to Enhance Cytotoxicity in Anticancer Therapy.
Nassiri M; Gopalan V; Vakili-Azghandi M
Curr Cancer Drug Targets; 2022; 22(5):373-387. PubMed ID: 35240973
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition.
Erickson HA; Jund MD; Pennell CA
Protein Eng Des Sel; 2006 Jan; 19(1):37-45. PubMed ID: 16243897
[TBL] [Abstract][Full Text] [Related]
15. [Antiviral activity of modified RNAses].
Alekseeva II; Kurinenko BM; Penzikova GA; Oreshina MG
Antibiotiki; 1982 May; 27(5):341-8. PubMed ID: 6179462
[TBL] [Abstract][Full Text] [Related]
16. [The influence of native ribonucleases and their modified derivatives on the functional activity of rat peritoneal macrophages].
Kalacheva NV; Kurinenko BM
Biomed Khim; 2005; 51(3):303-10. PubMed ID: 16104393
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis.
Spalletti-Cernia D; Sorrentino R; Di Gaetano S; Arciello A; Garbi C; Piccoli R; D'Alessio G; Vecchio G; Laccetti P; Santoro M
J Clin Endocrinol Metab; 2003 Jun; 88(6):2900-7. PubMed ID: 12788904
[TBL] [Abstract][Full Text] [Related]
18. From immunotoxins to immunoRNases.
De Lorenzo C; D'Alessio G
Curr Pharm Biotechnol; 2008 Jun; 9(3):210-4. PubMed ID: 18673286
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleases with angiogenic and bactericidal activities from the Atlantic salmon.
Pizzo E; Varcamonti M; Di Maro A; Zanfardino A; Giancola C; D'Alessio G
FEBS J; 2008 Mar; 275(6):1283-95. PubMed ID: 18279393
[TBL] [Abstract][Full Text] [Related]
20. [In vitro and in vivo studies of RNAse of Bacillus intermedius].
Kurinenko BM; Sergeeva EV; Sobchuk LI; Bulgakova RSh; Khaĭbullina SA
Antibiot Khimioter; 1989 Apr; 34(4):266-70. PubMed ID: 2751384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
